Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor–specified peripheral niche constraints
暂无分享,去创建一个
C. Benoist | D. Mathis | M. Feuerer | J. Nishio | J. Wong
[1] C. Benoist,et al. Genomic definition of multiple ex vivo regulatory T cell subphenotypes , 2010, Proceedings of the National Academy of Sciences.
[2] C. Benoist,et al. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. , 2009, Immunity.
[3] J. Lafaille,et al. TCR-dependent differentiation of thymic Foxp3+ cells is limited to small clonal sizes , 2009, The Journal of experimental medicine.
[4] Michael L. Dustin,et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo , 2009, The Journal of experimental medicine.
[5] W. Leonard,et al. New insights into the regulation of T cells by γc family cytokines , 2009, Nature Reviews Immunology.
[6] A. Rudensky,et al. Intraclonal competition limits the fate determination of regulatory T cells in the thymus , 2009, Nature Immunology.
[7] C. Hsieh,et al. Antigen-specific peripheral shaping of the natural regulatory T cell population , 2008, The Journal of experimental medicine.
[8] J. Sprent,et al. Homeostasis of naive and memory T cells. , 2008, Immunity.
[9] K. Herold,et al. Generation and function of human regulatory CD8+ T cells induced by a humanized OKT3 monoclonal antibody hOKT3gamma1 (Ala-Ala). , 2008, Human immunology.
[10] T. Malek,et al. A Function for IL-7R for CD4+CD25+Foxp3+ T Regulatory Cells1 , 2008, The Journal of Immunology.
[11] D. Vignali,et al. How regulatory T cells work , 2008, Nature Reviews Immunology.
[12] J. Bluestone,et al. CD3-specific antibody–induced immune tolerance involves transforming growth factor-β from phagocytes digesting apoptotic T cells , 2008, Nature Medicine.
[13] Yan Li,et al. Essential roles of TGF‐β in anti‐CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells , 2008, Journal of leukocyte biology.
[14] T. Hanke,et al. Characterization of mouse CD4 T cell subsets defined by expression of KLRG1 , 2007, European journal of immunology.
[15] Ansuman T. Satpathy,et al. Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes , 2007, Proceedings of the National Academy of Sciences.
[16] C. Benoist,et al. TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets , 2007, The Journal of experimental medicine.
[17] M. Battaglia,et al. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans , 2007, Nature Reviews Immunology.
[18] E. Shevach,et al. Distinct Subsets of FoxP3 Regulatory T Cells Participate in the Control of Immune Responses , 2007 .
[19] J. Bluestone,et al. Adaptive TGF-β-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment , 2007, Proceedings of the National Academy of Sciences.
[20] T. Chatila,et al. Regulatory T cell development in the absence of functional Foxp3 , 2007, Nature Immunology.
[21] J. Bluestone,et al. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. , 2006, The Journal of clinical investigation.
[22] J. Sprent,et al. Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes , 2006, Science.
[23] P. Burkett,et al. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. , 2006, Annual review of immunology.
[24] L. Hennighausen,et al. Stat5a/b are essential for normal lymphoid development and differentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[25] C. Benoist,et al. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes , 2005, The Journal of experimental medicine.
[26] J. Lohr,et al. Sequential development of interleukin 2–dependent effector and regulatory T cells in response to endogenous systemic antigen , 2005, The Journal of experimental medicine.
[27] M. Nussenzweig,et al. Inducing and expanding regulatory T cell populations by foreign antigen , 2005, Nature Immunology.
[28] A. Rudensky,et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells , 2005, Nature Immunology.
[29] Michel Goldman,et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. , 2005, The New England journal of medicine.
[30] J. Bluestone,et al. Treatment with Nonmitogenic Anti-CD3 Monoclonal Antibody Induces CD4+ T Cell Unresponsiveness and Functional Reversal of Established Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.
[31] Yasmine Belkaid,et al. Natural regulatory T cells in infectious disease , 2005, Nature Immunology.
[32] A. Rudensky,et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. , 2005, Immunity.
[33] P. Alard,et al. Conversion of CD4 CD25 cells into CD4 CD25 regulatory T cells in vivo requires B7 costimulation, but not the thymus , 2004 .
[34] C. Benoist,et al. Number of T Reg Cells That Differentiate Does Not Increase upon Encounter of Agonist Ligand on Thymic Epithelial Cells , 2004, The Journal of experimental medicine.
[35] J. Bluestone,et al. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes , 2003, Nature Medicine.
[36] R. Lechler,et al. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? , 2003, Blood.
[37] Brigitta Stockinger,et al. T Cell Regulation as a Side Effect of Homeostasis and Competition , 2003, The Journal of experimental medicine.
[38] Akemi Sakamoto,et al. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] P. Mottram,et al. Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies. , 2002, Transplant immunology.
[40] D. Harlan,et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. , 2002, The New England journal of medicine.
[41] C. Benoist,et al. Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes , 2001, Nature Immunology.
[42] S. Sakaguchi. Policing the regulators , 2001, Nature Immunology.
[43] A. Naji,et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide , 2001, Nature Immunology.
[44] C. Benoist,et al. Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes , 1998, The Journal of experimental medicine.
[45] J. Bluestone,et al. Nonmitogenic Anti-CD3 Monoclonal Antibodies Deliver a Partial T Cell Receptor Signal and Induce Clonal Anergy , 1997, The Journal of experimental medicine.
[46] J. Bluestone,et al. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. , 1995, Journal of immunology.
[47] L. Chatenoud,et al. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[48] C. Benoist,et al. Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.
[49] S. Carroll,et al. Anti-CD3 Immunotoxin Prevents Low-Dose STZ/Interferon-Induced Autoimmune Diabetes in Mouse , 1992, Diabetes.
[50] A. Montag,et al. Prevention of Autoimmune Diabetes With Nonactivating Anti-CD3 Monoclonal Antibody , 1992, Diabetes.
[51] A. Hayward,et al. Reduced incidence of insulitis in NOD mice following anti-CD3 injection: requirement for neonatal injection. , 1992, Journal of autoimmunity.
[52] D. Pardoll,et al. Thymic selection. , 1992, Current opinion in immunology.
[53] E. L. Calhoon. Immune therapy of cancer. , 1988, The Journal of the Oklahoma State Medical Association.
[54] M. Loken,et al. I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively. , 1982, Journal of immunology.